Quality Means Business (QMB Inc.) Raises $2M Seed to Launch QualiVerse®

The Boston Foundation’s Business Equity Investment Fund and CEI Ventures Back Category-Defining AI Platform Transforming MedTech Quality, Regulatory, and Product Development

Quality Means Business (QMB), an emerging leader in AI-driven MedTech SaaS, has closed a $2 million seed round to launch QualiVerse®, a Regulatory Intelligence Engine that helps medical device innovators achieve compliance, accelerate new product development, and scale safely to market. The round, led by The Boston Foundation’s Business Equity Investment Fund and CEI Ventures, positions QMB as a category-defining company at the intersection of AI, regulatory intelligence, and MedTech innovation.

“QMB is building the category infrastructure that MedTech has been missing. Michel’s vision is deeply informed by lived experience as both a regulator and SaaS product architect — and this is exactly the kind of entrepreneur we back to redefine industries.” — Anthony Rust, Fund Manager of the Business Equity Investment Fund

“We’re excited to support QMB in bringing critical innovation to the MedTech sector. QualiVerse® represents the type of transformative technology that not only drives business growth but also has the potential to improve patient outcomes on a global scale. This aligns perfectly with our mission to invest in companies that create meaningful economic opportunity while advancing social impact.” — Orlando Watkins, Vice President and Chief Program Officer of The Boston Foundation

“CEI Ventures is proud to partner with QMB. We’re especially proud that all current and planned jobs at QMB exceed the MIT Living Wage for Norfolk County, aligning with CEI Ventures’ Good Jobs Framework and our commitment to equitable, high-quality employment. QualiVerse® is the rare platform that marries technical sophistication with impact at scale — accelerating safer devices to patients worldwide.” — Shannon Bean, Principal, CEI Ventures

“Quality and regulatory are the unsung heroes of medical innovation — they safeguard lives while too often operating in the shadows. With QualiVerse®, we’re giving these teams the intelligent platform they deserve — a system that makes compliance not a bottleneck, but a catalyst for innovation. As both a MedTech regulatory veteran and product leader in enterprise SaaS, I know firsthand the cost of delay and the urgency of getting this right.” — Michel Moravia, Chairman & CEO of QMB

Building on early enterprise traction and pilot interest from leading device innovators, QMB will use the funding to expand engineering, deepen data integrations, and advance RegTech-as-Infrastructure pilots with MedTech manufacturers in late 2025.

Strategic Governance

• Michel Moravia, Chairman & CEO – 15+ years in MedTech regulatory and quality
• Orlando Watkins, Board Director – The Boston Foundation
• Robert Bennett, Board Director – Scaled EngageSmart® to PE acquisition
• Shannon Bean, Board Observer – CEI Ventures

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

The post Quality Means Business (QMB Inc.) Raises $2M Seed to Launch QualiVerse® first appeared on AI-Tech Park.